Regulatory Compliance

Hoffman Estates, Ill. – September 21, 2026 -- Omron Automation Americas has introduced the NXR-S Series Simple Logic Safety I/O Block, a distributed safety solution delivering response times as fast as 15 milliseconds while maintaining centralized CIP Safety management.

NXR-S combines local safety logic with centralized CIP Safety control

Unlike conventional remote safety I/O architectures, the IP67-rated NXR-S moves safety decisions closer to the point of action on the machine. Omron states this reduces overall system complexity and simplifies safety-distance design for manufacturers standardizing safety architectures across multiple machine lines.

Vilnius, Lithuania – September 21, 2026 -- SDK.finance has expanded its core platform strategy to help retailers, marketplaces, and telecom operators build native financial products, betting that established consumer brands rather than fintech startups will drive the next wave of payment innovation.

SDK.finance shifts platform focus toward non-financial consumer brands

The Vilnius-based software provider, which builds ready-made infrastructure for wallets and payments, said companies that already hold customer relationships and transaction data are better positioned to embed financial services than new fintech entrants. "None of these companies set out to be a bank, but all of them are moving money," said Pavlo Sidelov, CEO at SDK.finance.

Mexico City – September 21, 2026 -- The Association for the Accreditation of Human Research Protection Programs (AAHRPP) has awarded full accreditation to Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ), making it the first of Mexico's 13 National Institutes of Health under the Mexican Ministry of Health to reach this status.

INCMNSZ becomes only the second organization in Mexico to earn AAHRPP accreditation, joining a global roster that now exceeds 600 accredited entities. AAHRPP separately confirmed reaccreditation for five additional organizations, underscoring continued renewal activity within its existing accredited network.

Durham, N.C. – September 20, 2026 -- Accredit Solutions has launched Accredit Induct, a workforce readiness product that blocks credential issuance and site access until mandatory training and compliance requirements are verified as complete.

Platform links identity, training completion and access permissions into a single workflow

Built on the Accredit Platform and aligned with the Accredit OS operating model, Accredit Induct assigns role-based requirements, delivers digital induction content and tracks completion in real time. Unlike a standalone Learning Management System, the tool ties induction status directly to an individual's identity and credential record, making completion a condition of credential approval rather than a separate administrative record.

Norcross, Ga. – September 20, 2026 -- Koning Health's Breast CT System, the CBCT 1000, has been added to the Australian Register of Therapeutic Goods (ARTG No. 531059), clearing the device for commercial supply in Australia.

TGA approves device inclusion on September 8, 2026

The Therapeutic Goods Administration granted the ARTG listing on September 8, 2026, allowing Koning Health to begin commercial supply in Australia subject to regulatory conditions tied to the inclusion.

Brisbane Radiology becomes first Australian buyer of the system

Brisbane Radiology has committed to purchasing the Koning Breast CT System, making it the first provider in the country to adopt the technology. Clinical Director Jacqui Milne said the approval marks a milestone for breast imaging in Australia and expects it to create new opportunities for patients and providers nationwide.

Fort Worth, Texas – – September 20, 2026 -- IWP Capital, LLC said it will vote FOR Proposal 6 at FedEx Corporation's (NYSE: FDX) annual meeting on September 28, 2026, pressing the board to disclose how it manages legal exposure tied to shipping mail-order abortion drugs.

IWP Capital co-filed the proposal with the Catholic Diocese of Fort Worth

The measure, titled "Report on Risks Related to Distributing Abortion Drugs," appears in the Stockholder Proposals section of FedEx's 2026 proxy statement beginning on page 104. It is precatory, asking FedEx's board to issue a report within one year, at reasonable cost, detailing how it oversees legal, regulatory, and reputational risk linked to transporting drugs such as mifepristone. The proposal does not seek to halt shipments of any lawful product or mandate package inspections.

Hoboken, N.J. – September 20, 2026 -- Quantum Computing Inc. (Nasdaq: QUBT) will demonstrate, for the first time, a platform combining quantum key distribution (QKD) with hardware-based Quantum Identity Authentication (QIA) on a single system at ECOC Exhibition 2026, running September 21-23 at FYCMA in Málaga, Spain.

QCi merges encryption and authentication into one telecom-compatible architecture

At Booth #1436, the company will showcase high-dimensional QKD, direct entanglement verification, QIA and integrated key management combined in a single platform. Traditional QKD systems have faced barriers including scalability limits, operational complexity, high infrastructure costs and reliance on classical authentication methods, confining much of the technology to research settings rather than commercial deployment.

Geneva – September 20, 2026 -- China's leading hospitals serving international patients recorded 1.28 million international patient visits in 2025, up 73.6% from three years earlier, Dr. John K. Hsiang, Chairman of Jiahui Health's Executive Committee, said at the WTO Public Forum 2026.

Inbound patient volumes surge past 1.28 million visits in 2025

Of the 1.28 million total visits, 413,000 were made by patients who travelled to China specifically for medical care, according to data cited by Dr. Hsiang. At Jiahui Health, overseas patient inquiries nearly doubled year on year in the first half of 2026. Dr. Hsiang was the sole Chinese healthcare representative invited to the forum's "Health Without Borders" session on medical tourism in services trade.

Columbus, Ohio – September 20, 2026 -- Andelyn Biosciences has begun commercial manufacturing of FAYUVI (rebisufligene etisparvovec-hopf) at its Columbus facility, marking the first FDA-approved gene therapy produced using the company's AAV Curator Platform process. The therapy, developed by Ultragenyx Pharmaceutical Inc., recently received U.S. Food and Drug Administration approval for treating Sanfilippo syndrome type A, also known as mucopolysaccharidosis type IIIA (MPS IIIA).

FDA clears gene therapy for a rare, fatal childhood disease

MPS IIIA is a rare lysosomal storage disorder that drives rapid neurodegeneration starting in early childhood, primarily affecting the central nervous system. The disease impacts an estimated 3,000 to 5,000 patients worldwide, with a median life expectancy of 15 years.

Hamilton – September 20, 2026 -- Paratus Energy Services Ltd. confirmed that Petrobras has accepted a bid submitted by its Seagems joint venture for a third-party vessel under the state oil company's ongoing pipe-laying support vessel (PLSV) tender process for contracts starting in 2028.

Petrobras Publishes Partial Tender Results Favoring Seagems Bid

Petrobras has issued partial results from the tender, confirming acceptance of the bid covering the third-party vessel. The award remains subject to a formal Petrobras contract decision and the execution of definitive agreements between the parties.